- 询价
- Discovery® Antibodies（CRB）
- 英国
- crb2005089f
- 2025年07月08日
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 保存条件：
参照说明书
- 适应物种：
Human
- 目录编号：
crb2005089f
- 库存：
1
- 供应商：
北京博蕾德生物科技有限公司
- 抗体英文名：
Anti-FGFR2b antibody
- 抗体名：
Anti-FGFR2b antibody
- 规格：
100µg
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验Genotyping Anti-Hepatitis B Virus Drug Resistance
Agents available or in development for the treatment of chronic hepatitis B virus (HBV) infection fall into two major groups: immunomodulators, such as interferon-α and therapeutic vaccines, and nucleoside/nucleotide analogs
Induction of Anti-Hepatitis B Virus Immune Responses Through DNA Immunization
Cellular and humoral immune responses to different hepatitis B virus (HBV) antigens are believed to play an essential role in the elimination of virus by the host. It is well established that the humoral immune response to HBV envelope
Designing Clinical Development Programs for Anti-Hepatitis B Virus Drugs
Hepatitis B virus (HBV) infection remains one of the leading infectious causes of chronic liver disease and death in the world (1 ,2 ). With the advent of universal HBV vaccination and with the availability of antiviral therapeutics, HBV
技术资料暂无技术资料 索取技术资料
